Profile for Sangamo BioSciences, Inc. (SGMO)
« Back to company indexSGMO Chatter Timeline
Stock Ticker for SGMO
Most Active Tweeters for SGMO
| User | Tweets |
|---|---|
| @_B_I_O_T_E_C_H_ | 102 |
| @TraderSilver1 | 25 |
| @Biotech2050 | 20 |
| @Jaytanoo | 20 |
| @MaxPowerNGS | 18 |
Recent Tweets for SGMO
 |
@jbzstocks $SGMO possible divergence out of a falling wedge on the hourly https://t.co/hiKiBMu0s7 September 25th 2017, 10:09pm |
 |
@YuZhu4 RT @Biotech2050: $BIVV through $SGMO's platform provides hope for a #cure to #SickleCell disease sufferers. https://t.co/gJDJHob2Ks September 25th 2017, 3:09pm |
 |
@innatethoughts @Biotech2050 No reference to $SGMO at all in this. September 25th 2017, 3:09pm |
 |
@TraderSilver1 @Hall8Jack @beauregard2 $SGMO #ZFN is better than overhyped CRISPR September 25th 2017, 3:09pm |
 |
@_B_I_O_T_E_C_H_ RT @_B_I_O_T_E_C_H_: BOOOOM #ESGCT17 ApoE new AAV delivery ALZHEIMER !!!! Gene therapy approach treatment of Alzheimer’s $SGMO + colabs ht… September 25th 2017, 2:09pm |
 |
@Pond_Nostalgia RT @MaxPowerNGS: @Biotech2050 Just a matter of days for $SGMO TCR/CAR-T and Alzheimer's partnerships to be announced September 25th 2017, 2:09pm |
|
@_B_I_O_T_E_C_H_ RT @Biotech2050: Plasma Total-Tau Level May Flag CTE https://t.co/SdTWVHJk1K Maybe $SGMO TAU potential can help out September 25th 2017, 12:09pm |
 |
@darrenkay30 RT @_B_I_O_T_E_C_H_: a wise investment strategy could be...: to BUY THE SHIT OUT OF $SGMO !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! just imvho ? September 25th 2017, 12:09pm |
|
@MaxPowerNGS @Biotech2050 Just a matter of days for $SGMO TCR/CAR-T and Alzheimer's partnerships to be announced September 25th 2017, 11:09am |
 |
@Biotech2050 $BIVV through $SGMO's platform provides hope for a #cure to #SickleCell disease sufferers. https://t.co/gJDJHob2Ks September 25th 2017, 11:09am |
 |
@intercooleronli $9.42 Million in Sales Expected for Sangamo Therapeutics, Inc. $SGMO This Quarter https://t.co/N2S51Q3enp September 25th 2017, 11:09am |
 |
@CFinancialNews $9.42 Million in Sales Expected for Sangamo Therapeutics, Inc. $SGMO This Quarter https://t.co/KYttI0JCay September 25th 2017, 11:09am |
|
@_B_I_O_T_E_C_H_ a wise investment strategy could be...: to BUY THE SHIT OUT OF $SGMO !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! just imvho ? September 25th 2017, 10:09am |
 |
@BehaviorFin $SGMO going to test $13.3? September 25th 2017, 10:09am |
|
@Jaytanoo @tgtxdough BARRONS CAN EASILY MOVE STOCK PRICES AND HAS ALWAYS DONE SO.. $RGNX $SGMO September 25th 2017, 10:09am |
|
@Biotech2050 RT @_B_I_O_T_E_C_H_: $SGMO over 20 next 2-4 weeks imvho #esgct17 et all mark this post shorty September 25th 2017, 9:09am |
|
@_B_I_O_T_E_C_H_ RT @_B_I_O_T_E_C_H_: $RGNX up 10% on the barrons pump ... $SGMO mentionend later in article but not so promintnt... might need another minu… September 25th 2017, 9:09am |
|
@_B_I_O_T_E_C_H_ $RGNX up 10% on the barrons pump ... $SGMO mentionend later in article but not so promintnt... might need another minute or so to pop ? September 25th 2017, 9:09am |
|
@_B_I_O_T_E_C_H_ $SGMO over 20 next 2-4 weeks imvho #esgct17 et all mark this post shorty September 25th 2017, 9:09am |
|
@_B_I_O_T_E_C_H_ bought more $SGMO shares from the insane dippers here at 13.55 txs $ABUS September 25th 2017, 9:09am |
 |
@wyv_123 @_B_I_O_T_E_C_H_ $SGMO hmm who has the best AAV delivery, most experience and most patents in this area? Should be… https://t.co/ENTP3Y2tE6 September 25th 2017, 9:09am |
|
@_B_I_O_T_E_C_H_ BOOOOM #ESGCT17 ApoE new AAV delivery ALZHEIMER !!!! Gene therapy approach treatment of Alzheimer’s $SGMO + colabs https://t.co/IxqCQqpMNp September 25th 2017, 9:09am |
 |
@WealthMDs RT @mgutierrez_apex: Jefferies: ESGCT Titles Posted: $ABEO , $SGMO , and More... September 25th 2017, 8:09am |
 |
@dailymailtimes Insider Selling: Sangamo Therapeutics, Inc. $SGMO Director Sells $445,470.00 in Stock https://t.co/5XhJLAQmmj September 25th 2017, 5:09am |
 |
@WKRBNews Insider Selling: Sangamo Therapeutics, Inc. $SGMO Director Sells $445,470.00 in Stock https://t.co/kD3EBmDPSx September 25th 2017, 5:09am |
 |
@midetimes Insider Selling: Sangamo Therapeutics, Inc. $SGMO Director Sells $445,470.00 in Stock https://t.co/CH5vokEzqX September 25th 2017, 5:09am |
 |
@dailypoliticaln Insider Selling: Sangamo Therapeutics, Inc. $SGMO Director Sells $445,470.00 in Stock https://t.co/5yY4Mqz7qa September 25th 2017, 5:09am |
|
@MaxPowerNGS Tutorial on how to hijack a great message board on $SGMO through repetitive, simple, & meaningless subject headers. https://t.co/fJsf054SXM September 24th 2017, 1:09pm |
 |
@TranscriptDaily William R. Ringo Sells 31,000 Shares of Sangamo Therapeutics, Inc. $SGMO Stock https://t.co/m3Hd7vzEiM September 24th 2017, 6:09am |
|
@windham_kathryn Deerfield Management Company Raised By $2.05 Million Its Sangamo Therapeutics $SGMO Stake ... September 24th 2017, 5:09am |
 |
@TheMarketsDaily Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Sangamo Therapeutics $SGMO Stock Price https://t.co/PyDodYlaot September 24th 2017, 5:09am |
 |
@SleekMoneycom Sangamo Therapeutics’ $SGMO Outperform Rating Reaffirmed at Wells Fargo & Company https://t.co/oqKcsmEKTh September 24th 2017, 2:09am |
|
@innatethoughts @_B_I_O_T_E_C_H_ $SGMO is not talked about much at all in this column. September 24th 2017, 1:09am |
 |
@WatchlistN Sangamo Therapeutics, Inc. $SGMO Director William R. Ringo Sells 31,000 Shares of Stock https://t.co/cEVrq6XTqU September 23rd 2017, 3:09pm |
|
@TraderSilver1 RT @_B_I_O_T_E_C_H_: $SGMO #ESGCT17 In vivo genome editing via #nonviral delivery of ZFN supraphy levels of therap proteins +greater than 9… September 23rd 2017, 2:09pm |
|
@_B_I_O_T_E_C_H_ RT @_B_I_O_T_E_C_H_: $SGMO #ESGCT17 "New zinc finger nuclease architectures for precision genome engineering in the development of #novel #… September 23rd 2017, 1:09pm |
|
@_B_I_O_T_E_C_H_ RT @_B_I_O_T_E_C_H_: $SGMO #esgct17 Gene therapy approach for treatment of #Alzheimer’s Targeting apolipoproteinE with #novel AAV vectors d… September 23rd 2017, 1:09pm |
|
@_B_I_O_T_E_C_H_ RT @Biotech2050: @_B_I_O_T_E_C_H_ So much going on at $SGMO that it is hard to keep track https://t.co/NDIydGfzxC September 23rd 2017, 10:09am |
|
@Biotech2050 Plasma Total-Tau Level May Flag CTE https://t.co/SdTWVHJk1K Maybe $SGMO TAU potential can help out September 23rd 2017, 7:09am |
|
@Biotech2050 @_B_I_O_T_E_C_H_ So much going on at $SGMO that it is hard to keep track https://t.co/NDIydGfzxC September 23rd 2017, 5:09am |
|
@_B_I_O_T_E_C_H_ $SGMO #esgct17 Gene therapy approach for treatment of #Alzheimer’s Targeting apolipoproteinE with #novel AAV vectors delivered systemically September 23rd 2017, 5:09am |
|
@BehaviorFin $Sgmo -3.8% today. Sp tries to find lower level and then momentum to sustainably break major resistance @ 14.5 after 2 previous attempts September 23rd 2017, 3:09am |
|
@dakotafinancial William R. Ringo Sells 31,000 Shares of Sangamo Therapeutics, Inc. $SGMO Stock https://t.co/1wpAbRDIPM September 22nd 2017, 7:09pm |
|
@CFinancialNews William R. Ringo Sells 31,000 Shares of Sangamo Therapeutics, Inc. $SGMO Stock https://t.co/t4NJhZOpr2 September 22nd 2017, 7:09pm |
|
@wyv_123 $SGMO Independent director William Rengo sold his shares yesterday. He's affilated w/ $PFE and lots of other bios. https://t.co/9g26VjwOlq September 22nd 2017, 5:09pm |
|
@darrenkay30 RT @Biotech2050: $SGMO HALT!! ? ? ? Just testing your nerves Have a great weekend September 22nd 2017, 4:09pm |
 |
@mgutierrez_apex INV75 New zinc finger nuclease architectures for precision genome engineering in development of novel genomic therapie; Michael Holmes $SGMO September 22nd 2017, 4:09pm |
|
@mgutierrez_apex $SGMO title -- potentially additional details/context relative to what was presented at ASGCT'17 regarding new ZFN architectures September 22nd 2017, 4:09pm |
|
@mgutierrez_apex Jefferies: ESGCT Titles Posted: $ABEO , $SGMO , and More... September 22nd 2017, 4:09pm |
|
@_B_I_O_T_E_C_H_ $SGMO #ESGCT17 In vivo genome editing via #nonviral delivery of ZFN supraphy levels of therap proteins +greater than 90% protein knockdown.. September 22nd 2017, 4:09pm |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.